Febuvel 40mg Tablet contains Febuxostat, a xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, Febuxostat reduces the production of uric acid in the body, thereby helping to prevent gout attacks and the formation of urate crystals in joints and tissues. This medication is typically prescribed for individuals who have not responded well to other urate-lowering therapies or who are intolerant to allopurinol. Febuvel 40mg is taken orally, usually once daily, with or without food, as directed by a healthcare professional. It is important to maintain adequate hydration while on this medication to help prevent kidney stones. Patients should inform their doctor about any history of liver or kidney disease, cardiovascular conditions, or allergies before starting treatment. Common side effects may include nausea, joint pain, rash, or liver enzyme abnormalities, and any unusual symptoms should be reported promptly. Regular monitoring of uric acid levels and liver function tests is recommended during therapy to ensure safety and efficacy. Febuvel 40mg provides an effective option for long-term management of gout and hyperuricemia, improving patient quality of life by reducing flare-ups and complications associated with elevated uric acid levels.